Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GPhA’s Deficit Reduction Proposals Focus On Medicare Low-Income Subsidy, REMS Policies

This article was originally published in The Pink Sheet Daily

Executive Summary

In letters to congressional leaders, generic drug trade group outlines six proposals that it says would save the government billions of dollars and lessen the impact of sequestration cuts.

Advertisement

Related Content

Brand, Generic Disputes Over Access Move Beyond REMS Restrictions
Raising Part D Donut Hole Discounts To 75% Proposed By President
Raising Part D Donut Hole Discounts To 75% Proposed By President
GPhA’s Goals For 2013: Smooth GDUFA Implementation, Workable Biosimilar Pathway
Senate Prevails On PDUFA Antibiotic Incentive As House Vote Nears
Generics: Capitol Hill’s Super “Pay For”
GPhA’s Neas Preaches Vigilance Against Reopening Hatch-Waxman Act
Cost-Sharing Incentives Would Drive Higher Generic Drug Use By Low-Income Enrollees In Part D - MedPAC
Senate Bill Aims To Incentivize Generic Substitution In Medicaid
Medicaid Reform: Teva Wants Payments To Encourage Generic Substitution

Topics

Advertisement
UsernamePublicRestriction

Register

PS075425

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel